Cardiac resynchronization therapy: mechanisms of action and scope for further improvement in cardiac function

Siana Jones, Joost Lumens, S. M. Afzal Sohaib, Judith A. Finegold, Prapa Kanagaratnam, Mark Tanner, Edward Duncan, Philip Moore, Francisco Leyva, Mike Frenneaux, Mark Mason, Alun D. Hughes, Darrel P. Francis*, Zachary I. Whinnett, BRAVO Investigators

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Cardiac resynchronization therapy (CRT) may exert its beneficial haemodynamic effect by improving ventricular synchrony and improving atrioventricular (AV) timing. The aim of this study was to establish the relative importance of the mechanisms through which CRT improves cardiac function and explore the potential for additional improvements with improved ventricular resynchronization.

We performed simulations using the CircAdapt haemodynamic model and performed haemodynamic measurements while adjusting AV delay, at low and high heart rates, in 87 patients with CRT devices. We assessed QRS duration, presence of fusion, and haemodynamic response. The simulations suggest that intrinsic PR interval and the magnitude of reduction in ventricular activation determine the relative importance of the mechanisms of benefit. For example, if PR interval is 201 ms and LV activation time is reduced by 25 ms (typical for current CRT methods), then AV delay optimization is responsible for 69% of overall improvement. Reducing LV activation time by an additional 25 ms produced an additional 2.6 mmHg increase in blood pressure (30% of effect size observed with current CRT). In the clinical population, ventricular fusion significantly shortened QRS duration (Delta-27 +/- 23 ms, P <0.001) and improved systolic blood pressure (mean 2.5 mmHg increase). Ventricular fusion was present in 69% of patients, yet in 40% of patients with fusion, shortening AV delay (to a delay where fusion was not present) produced the optimal haemodynamic response.

Improving LV preloading by shortening AV delay is an important mechanism through which cardiac function is improved with CRT. There is substantial scope for further improvement if methods for delivering more efficient ventricular resynchronization can be developed.

Original languageEnglish
Pages (from-to)1178-1186
Number of pages9
JournalEP Europace
Issue number7
Publication statusPublished - Jul 2017


  • Resynchronization
  • Cardiac resynchronization therapy
  • CRT
  • AV delay
  • CRT mechanisms


Dive into the research topics of 'Cardiac resynchronization therapy: mechanisms of action and scope for further improvement in cardiac function'. Together they form a unique fingerprint.

Cite this